Patrick Bock

Cleary Gottlieb Steen & Hamilton (Cologne)
Lawyer (Partner)

Patrick R. Bock is a partner based in the Cologne office. Mr. Bock’s practice focuses on antitrust counseling and antitrust litigation. Mr. Bock joined the firm in 2003 and became a partner in 2013. From 2003 to 2007, he was resident in the Washington, D.C. office, from 2008 to 2009, he was resident in the Brussels office and from 2009 to 2013, he was resident in the Washington, D.C. office. He received a J.D. degree from Harvard Law School in 2003 and an undergraduate degree in Economics and International Studies, magna cum laude, from Yale University in 2000. Mr. Bock is recognized as a leading antitrust lawyer by The Legal 500 U.S. Mr. Bock is a member of the Bars in Illinois and the District of Columbia. His native languages are English and German, and he is also proficient in French.

Linked authors

Cleary Gottlieb Steen & Hamilton (Washington)
Cleary Gottlieb Steen & Hamilton (Washington)

Articles

731 Bulletin

Jeremy J. Calsyn, Patrick Bock The US FTC imposes conduct remedies prior to clearing a vertical merger causing anticompetitive concerns in the soft drink industry (PepsiCo / Pepsi Bottling)

132

After a decade of what was perceived by many as relatively restrained merger enforcement, the Obama administration has repeatedly and vocally vowed to “reinvigorate antitrust enforcement” and to “take effective action to stop or restructure mergers that are likely to harm consumer[s]”. Many (...)

Jeremy J. Calsyn, Patrick Bock The US DoJ seeks to divest part of the business and require the licensing of software in order to mitigate anticompetitive effects of a merger in the ticketing services industry (Ticketmaster / Live Nation)

147

After a decade of what was perceived by many as relatively restrained merger enforcement, the Obama administration has repeatedly and vocally vowed to “reinvigorate antitrust enforcement” and to “take effective action to stop or restructure mergers that are likely to harm consumer[s]”. Many (...)

Jeremy J. Calsyn, Patrick Bock The US FTC employs a creative remedy, requiring the offer of divestiture to determine the existence of a viable alternative purchaser, before approving the merger of acute care hospitals (King’s Daughters Hospital / Scott & White)

192

After a decade of what was perceived by many as relatively restrained merger enforcement, the Obama administration has repeatedly and vocally vowed to “reinvigorate antitrust enforcement” and to “take effective action to stop or restructure mergers that are likely to harm consumer[s]”. Many (...)

Send a message